{"record":{"code":"W-02647","indicator":"Debarred / sanctioned abroad × US SEC issuer","class_b":false,"subject":"BMY · SUB~ · BR · ESTADO DO ACRE","buyer":"","amount":51316223.76,"currency":null,"records":2,"found":"2026-10-04","refs":["ocds-ye9ov3-63606479000124_2026_132","2015-10-05"],"id":"W-02647","html":"https://worldwide-corruption.com/record/brazil/findings/fcpa-pattern/W-02647/","json":"https://worldwide-corruption.com/record/brazil/findings/fcpa-pattern/W-02647/index.json","why":"Indicator “Debarred / sanctioned abroad × US SEC issuer”: looks like a subsidiary 'BRISTOL MYERS SQUIBB A ~0.76' «BRISTOL-MYERS SQUIBB FARMACEUTICA LTDA - (BMS)» ↔ SEC BMY (CIK 14272, BRISTOL MYERS SQUIBB CO): 2 non-competitive contracts at the buyer «ESTADO DO ACRE», 285,090,132 BRL (≈ $51,316,224); method direct (tipoInstrumentoConvocatorioCodigo: 3; tipoInstrumentoConvocatorioNome: Ato que autoriza a Contratação Direta; modalidadeId: 9; modalidadeNome: Inexigibilidade; modoDisputaId: 5; modoDis; OCID ocds-ye9ov3-63606479000124_2026_132; ⚑ REPEAT: already sanctioned SEC by FCPA (2015-10-05 Bristol-Myers Squibb); ↓ weak method (catalogue / exclusivity / accreditation / small purchase).","facts":[["Company / subject","BMY · SUB~ · BR · ESTADO DO ACRE",null],["Indicator","Debarred / sanctioned abroad × US SEC issuer",null],["Amount","51,316,224",null],["Records behind the indicator","2",null],["Found","4 October 2026",null],["Code","W-02647",null],["Reference","ocds-ye9ov3-63606479000124_2026_132",null],["Reference","2015-10-05",null]],"summary":"looks like a subsidiary 'BRISTOL MYERS SQUIBB A ~0.76' «BRISTOL-MYERS SQUIBB FARMACEUTICA LTDA - (BMS)» ↔ SEC BMY (CIK 14272, BRISTOL MYERS SQUIBB CO): 2 non-competitive contracts at the buyer «ESTADO DO ACRE», 285,090,132 BRL (≈ $51,316,224); method direct (tipoInstrumentoConvocatorioCodigo: 3; tipoInstrumentoConvocatorioNome: Ato que autoriza a Contratação Direta; modalidadeId: 9; modalidadeNome: Inexigibilidade; modoDisputaId: 5; modoDis; OCID ocds-ye9ov3-63606479000124_2026_132; ⚑ REPEAT: already sanctioned SEC by FCPA (2015-10-05 Bristol-Myers Squibb); ↓ weak method (catalogue / exclusivity / accreditation / small purchase)","entity":"33c63417"},"about":"Indicators computed from public data sets: contracts, payments, registers, trade and sanctions lists. An indicator is a reason to check, not a decision of a public authority.","evidence":[],"row":{"country":"Brazil","iso2":"BR","part":"Findings","indicator":"Debarred / sanctioned abroad × US SEC issuer","about":"Indicators computed from public data sets: contracts, payments, registers, trade and sanctions lists. An indicator is a reason to check, not a decision of a public authority.","findings":1312,"new_today":0,"on_pages":1312,"full_list":[],"html":"https://worldwide-corruption.com/database/brazil/findings/fcpa-pattern/","json":"https://worldwide-corruption.com/database/brazil/findings/fcpa-pattern/index.json"},"other_records_of_this_company":[],"html":"https://worldwide-corruption.com/record/brazil/findings/fcpa-pattern/W-02647/","json":"https://worldwide-corruption.com/record/brazil/findings/fcpa-pattern/W-02647/index.json"}